| 1 |
Recombinant protein production-associated metabolic burden reflects anabolic constraints and reveals similarities to a carbon overfeeding response
Li ZP, Rinas U
Biotechnology and Bioengineering, 118(1), 94, 2021 |
| 2 |
Heparin: role in protein purification and substitution with animal-component free material
Bolten SN, Rinas U, Scheper T
Applied Microbiology and Biotechnology, 102(20), 8647, 2018 |
| 3 |
Properties of dimeric, disulfide-linked rhBMP-2 recovered from E. coli derived inclusion bodies by mild extraction or chaotropic solubilization and subsequent refolding
Quaas B, Burmeister L, Li ZP, Nimtz M, Hoffmann A, Rinas U
Process Biochemistry, 67, 80, 2018 |
| 4 |
Purification of bone morphogenetic protein-2 from refolding mixtures using mixed-mode membrane chromatography
Gieseler G, Pepelanova I, Stuckenberg L, Villain L, Nolle V, Odenthal U, Beutel S, Rinas U, Scheper T
Applied Microbiology and Biotechnology, 101(1), 123, 2017 |
| 5 |
Functional Inclusion Bodies Produced in Bacteria as Naturally Occurring Nanopills for Advanced Cell Therapies
Vazquez E, Corchero JL, Burgueno JF, Seras-Franzoso J, Kosoy A, Bosser R, Mendoza R, Martinez-Lainez JM, Rinas U, Fernandez E, Ruiz-Avila L, Garcia-Fruitos E, Villaverde A
Advanced Materials, 24(13), 1742, 2012 |
| 6 |
Inclusion bodies of fuculose-1-phosphate aldolase as stable and reusable biocatalysts
Sans C, Garcia-Fruitos E, Ferraz RM, Gonzalez-Montalban N, Rinas U, Lopez-Santin J, Villaverde A, Alvaro G
Biotechnology Progress, 28(2), 421, 2012 |
| 7 |
Simple defined autoinduction medium for high-level recombinant protein production using T7-based Escherichia coli expression systems
Li ZP, Kessler W, van den Heuvel J, Rinas U
Applied Microbiology and Biotechnology, 91(4), 1203, 2011 |
| 8 |
Optimized procedure to generate heavy isotope and selenomethionine-labeled proteins for structure determination using Escherichia coli-based expression systems
Li ZP, Nimtz M, Rinas U
Applied Microbiology and Biotechnology, 92(4), 823, 2011 |
| 9 |
Preparation of bioactive soluble human leukemia inhibitory factor from recombinant Escherichia coli using thioredoxin as fusion partner
Tomala M, Lavrentieva A, Moretti P, Rinas U, Kasper C, Stahl F, Schambach A, Warlich E, Martin U, Cantz T, Scheper T
Protein Expression and Purification, 73(1), 51, 2010 |
| 10 |
Agitation effects on morphology and protein productive fractions of filamentous and pelleted growth forms of recombinant Aspergillus niger
El-Enshasy H, Kleine J, Rinas U
Process Biochemistry, 41(10), 2103, 2006 |
